Two cases of angiosarcoma of the breast are presented. They are of particular interest in that one patient is a long-term survivor, the 19th reported to date, and the other presented with contralateral breast involvement without evidence of disseminated disease. The world literature is reviewed and
Angiosarcoma: A report of 67 patients and a review of the literature
β Scribed by Rufus J. Mark; Joseph C. Poen; Luu M. Tran; Yao S. Fu; Guy F. Juillard
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 728 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND. Angiosarcomas (AS) are rare, aggressive tumors. Optimal treatment has not been well defined. The authors undertook a retrospective review of patients seen at their institution with the intent of identifjmg prognostic factors and optimal treatment strategies. Between 1955 and 1990, 67 patients with AS were seen at the University of California, at Los Angeles Medical Center. Follow-up ranged from 1 to 173 months with a median of 30 months.
METHODS.
RESULTS.
The overall prognosis was poor. The actuarial 2-and 5-year disease free suMvals (DFS) were 44% and 24%, respectively. Of 52 recurrences after primary treatment, 81% (42 of 52) had a component of local failure. Twenty-eight patients had developed distant metastases at last follow-up. Of patients who received surgery (S) and radiation therapy (RT), with or without chemotherapy (CT), 5-year actuarial DFS was 43% compared with 17% for patients who underwent S+/-CT as initial treatment (P = 0.03). Only 9% of patients (1 of 11) treated with RT+/ -CT were rendered free of disease.
CONCLUSIONS.
Patients with AS usually present with high grade histology, and with multifocal disease. There is a propensity for both local recurrence and distant metastases. Our results and a review of the literature, suggest that S plus RT offers the best chance for long term control of this aggressive tumor. The role of CT remains undefined.
π SIMILAR VOLUMES
## BACKGROUND. Second malignancies are a well recognized complication of radiation therapy. ## METHODS. We performed a computer search of the literature using the Medline Database for Pericardial Tumors and Post-Irradiation Sarcomas. ## RESULTS. The case history of a patient who developed a
tenance therapy in patients with APL because of concern 4
BACKGROUND. Angiosarcoma (AS) accounts for 1 to 2% of all soft tissue sarcoma. Both primary and secondary AS may occur, the latter being reported in the upper extremity with lymphedema after extended radical mastectomy for breast cancer (postmastectomy AS) or following radiotherapy of the breast, t